ENST00000650300.1:n.356C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000650300.1(ENSG00000285955):n.356C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.234 in 152,162 control chromosomes in the GnomAD database, including 4,399 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).
Frequency
Genomes: 𝑓 0.23 ( 4399 hom., cov: 34)
Consequence
ENSG00000285955
ENST00000650300.1 non_coding_transcript_exon
ENST00000650300.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.125
Publications
294 publications found
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
HTRA1 Gene-Disease associations (from GenCC):
- CARASIL syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- genetic cerebral small vessel diseaseInheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
- HTRA1-related autosomal dominant cerebral small vessel diseaseInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.409 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTRA1-AS1 | XR_946382.3 | n.378C>T | non_coding_transcript_exon_variant | Exon 1 of 3 | ||||
HTRA1-AS1 | XR_946383.3 | n.356C>T | non_coding_transcript_exon_variant | Exon 1 of 4 | ||||
HTRA1-AS1 | XR_946384.3 | n.356C>T | non_coding_transcript_exon_variant | Exon 1 of 4 | ||||
HTRA1-AS1 | XR_946385.3 | n.356C>T | non_coding_transcript_exon_variant | Exon 1 of 3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000285955 | ENST00000650300.1 | n.356C>T | non_coding_transcript_exon_variant | Exon 1 of 3 | ||||||
HTRA1 | ENST00000648167.1 | c.154+2319G>A | intron_variant | Intron 1 of 8 | ENSP00000498033.1 |
Frequencies
GnomAD3 genomes AF: 0.234 AC: 35620AN: 152042Hom.: 4389 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
35620
AN:
152042
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.234 AC: 35666AN: 152162Hom.: 4399 Cov.: 34 AF XY: 0.237 AC XY: 17634AN XY: 74384 show subpopulations
GnomAD4 genome
AF:
AC:
35666
AN:
152162
Hom.:
Cov.:
34
AF XY:
AC XY:
17634
AN XY:
74384
show subpopulations
African (AFR)
AF:
AC:
9738
AN:
41542
American (AMR)
AF:
AC:
3521
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
722
AN:
3468
East Asian (EAS)
AF:
AC:
2176
AN:
5130
South Asian (SAS)
AF:
AC:
1528
AN:
4832
European-Finnish (FIN)
AF:
AC:
2487
AN:
10596
Middle Eastern (MID)
AF:
AC:
59
AN:
292
European-Non Finnish (NFE)
AF:
AC:
14721
AN:
67968
Other (OTH)
AF:
AC:
498
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1484
2967
4451
5934
7418
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1277
AN:
3478
ClinVar
Significance: risk factor
Submissions summary: Other:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Age related macular degeneration 7 Other:1
Feb 18, 2015
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Susceptibility to neovascular type of age-related macular degeneration Other:1
Feb 18, 2015
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.